we are waiting for earnings from mylan, electronic arts groupon and pioneer energy.ng you those numbers as they cross. we talked about first quarter growth. what are we seeing in the treasury markets? we see a climb up in yields over 2% despite the murky data. guest: we have gone from deflation scares which were predicated on file -- on falling oil prices. i don't buy into that story, but nonetheless, that was happening. forecasts continually downgraded across the quarter from 3% growth at the start of the year two a lousy 1% growth forecasted last week and we got even worse than that. now we see evidence the economy is improving and deflation concerns were overblown. so naturally you should see some backup and treasury yields. guest: we have had a positive surprise in weakness. europe we rode off at the beginning of the year and we are getting strong surprises. the ecb did this cutie program and the euro came down. it was a big benefit and now it looks like it is actually working. what happened today is expectation in the futures market got moved forward. instead of

guy adami, reaction to mylan or ea? >> ea i think is interesting.for the last couple of months. i think it continues higher off of this. i think the short interest is close to 7%. they're going to get squeezed. it will push up towards 70 bucs. bucks, a level we topped out at 75 or so. >> go buy yourself an nhl '15. maybe you'll actually make it to the stanley cup finals. >> thatnk you, guy. >> i love scott. i love hockey man. >> so do people buying that video game from electronic arts. >> be sure to stick around and catch guy adami talking stocks and hockey and more at 5:00 on "fast money." he'll be asking the former s.e.c. chairman harvey pitt why the flash crash could be sooner than we think. >>> chaipotle did away with genetically modified organisms, now panera is this about healthier eating or a marketing campaign? we talk to the ceo and co-founder ron shaich. he joins us next in a first on cnbc interview. >>> salesforce shares surging on a report microsoft is mulling a bid for the tech giant. is that a good fit? or is there another buyer waitin

mylan shares were up the day they announced for perrigo.because they knew teva might be coming for them. frankly, it may not be teva that motivated my larkslan. an activist that's motivated a guy to continue to want to acquire. which by the way, they've been doing for years and years to quiet positive effect for shareholders. >> look at this for yesterday. bye, bye, bye. >> it's worked. >> models work. >> models work. the question is what happens there? who knows. >> the hatred. >> yeah it is. >> it is unusual. although correy simply believes they're headed down the wrong track with multiple different managements at this point and would not be in any way shape or form the right fit. >> there was a delta house who commented about the board. >> right. >> dean i love that. >> what college was that? >> oh let's see. what was the name of that college. >> we've been on fire on the animal house. >> we have. don't forget knowledge is good. all right. let's head to the scene in chicago. rick. >> well thank you very much david. today we're only up on

. >> mylan.ompany chairman has been meeting with lots of fund managers and giving them his strong opinion why selling to teva would be a big mistake. we haven't heard from teva in a while. there is an expectation still perhaps teva will raise its bid. we will see. he's been very aggressive in terms of articulating why a sale to teva would be a very bad idea, and why he believes the stock price of mylan, if they were to do the perigo deal -- >> there was a lot of chatter on the activist call whether he should spin off his business. there is a free for all in generics. i mentioned the ms franchise. the clock is ticking on teva. >> they migrated a lot of their patient population from 20 milligrams to 40. mylan bringing them on the 40 milligram dosage and the way it's done and patent challenges. it's a big, big percentage of profits. that being said mylan for its part the epi-pen, do you know how much money they make on the epi-pen? enormous amounts. they raised the price dramatically. over the last

mylan is domiciled in them -- in the netherlands. mylan could go in by -- and buy sandoz.is is not coming from the other companies. the one thing they are adamant about is they will not sell themselves to teva. anna: complicated stuff. thank you. manus: coming up, we speak to the ceo of easyjet. a profit for the first half. anna: >> the first time since 2002 they have turned a profit. we will talk to carolyn record about that and their forecast for the euro. that is still working in their favor. manus: stay tuned. that conversation coming up straight after this break. ♪ just because i'm away from my desk doesn't mean i'm not working. comcast business understands that. their wifi isn't just fast near the router. it's fast in the break room. fast in the conference room. fast in tom's office. fast in other tom's office. fast in the foyer [pronounced foy-yer] or is it foyer [pronounced foy-yay]? fast in the hallway. i feel like i've been here before. switch now and get the fastest wifi everywhere. comcast business. built for business. manus: welcome back to "countdown." we had

last month mylan rejected teva's $40 billion takeover attempt. a federal court says broadcasters will not have to turn over sensitive video programming documents as part of the government's review of the at&t direct tv deal. the court ruled that the fcc did not prove that the confidential information from cbs, disney, and others was necessary to the merger review process. a.o.l. shares are rising the most in 16 months. the company reported a 7% gain in first quarter sales and turned a profit of $7 million. a.o.l. has shifted the focus to digital advertising and sales at its platforms unit which includes digital advertising growing 21%. now, to the lead. hoover is willing to spend billions to buy one of the world's largest digital mapping services. the "new york times" says uber has submitted a bid of up to $3 billion for nokia's mapping business known as here. nokia's map business has an 80% marketshare for built in car navigation services. uber's bid is competing with another one from a group of german automakers including b.m.w., audi, and merc

to buy mylan and mylan rejected the offer saying it grossry overvalued the company and pursuing its own >>> fresh off of their annual meeting southern company is announcing they reached a battery testing agreement with tesla motors. they'll test commercial scale battery storage and energy storage technology to help meet customers' energy needs. joining us now to talk about this is tom fanning. chairman, president and ceo of southern company. nick atkins is chairman president and ceo of american electric power and our guest host today is david steiner of waste management. gentlemen, thank you. the reason we have you all here is you are both customers of david's. why don't we explain that relationship first? >> well one thing about the electric utility industry is they have been doing recycling for years and years and years. no one recycles more material than the electric utility industry. they're using leftover coal ash to do road beds and all sorts of different beneficial uses. and then what we do is we work with the plants to also get the inside of the plants more green. and, so the co

to raise about $25 billion in financing -- the money would be used to back its unsolicited bid for mylan. teva has yet to decide the size of any potential increase. myla says it wants to stay independent. the world's largest maker of chemicals has rejected a $45 billion takeover offer from monsanto. the offer undervalues the company and does not reflect its growth prospects. the combination would create the biggest supplier of seeds and crop chemicals. monsanto dominates the market for gmo's. that's a look at the top stories we are following on this friday. more now on the rebound in u.s. hiring. he was chief economist at rbs joins me from stamford connecticut. welcome back to "bottom line." michelle what were the main takeaways from the april employment report? shell: the biggest takeaways that everything is ok. -- michelle: the march report was so disappointing. while the april number was not gangbusters, it wasn't the same job growth we saw at the end of 2014, the number we see is very solid, even looking at the three-month trend of just under 200,000. these are solid numbers that are

last one, mylan rejected the takeover offer. a federal court says broadcasters will not have to turn oversensitive documents to the fcc as part of the government's review of the at&t directv deal. the court ruled the fcc did not deem it necessary to the process. aol shares are rising the most in 16 months. the company reported a 7% gain in first-quarter sales and turned a profit of $7 million. they have shifted their focus to digital advertising and sales. now to the lead. hoover is willing to spend billions to buy one of the world's largest digital mapping services. uber has submitted a bid of up to $3 billion for new kia's -- nokia's mapping business. uber's bid is competing with another one from a group of german automakers including bmw, audi, and mercedes-benz. they are also teaming up with baidu on their offer. joining us is cory johnson. with me in the studio is the mapping expert,. i am so glad you are here today because we are all wondering what is so special about nokia m aps? >> since they announced, there have been a

i spent a lot of time lately getting to know dutch law as it relates to mylan. as for swiss takeover law, i'm not as familiar with it. i believe they mention stake holders in their response. when you hear stakeholders you know a company may have a lot more to go on in rejecting than simply saying no to price. at this point, it does appear they've been stymied yet again. >> what does this mean to you? you put it into the bigger picture. you asked if this is a new thing when it comes to m&a. is it a broader statement with the markets? >> i feel because of yelp and salesforce.com, they say takeover rumors are flying. this is gigantic bid. consolidation would be incredible. the pharmas are -- this is a really important deal. i think sometimes we get caught up in rates and not looking at the big picture. there are companyies furiously trying to combine what they think is a lenient justice department. i think the justice department is not lenient and we need telco consolidation. both stocks are flying. they are going higher. >> question as to whether monsanto down the

. >>> and israel's teva pharmaceuticals disclosing a 1.35% stake in mylan. you might recall mylan rejected the offer calling it grossly undervalued. >>> tomorrow is may 29th. 5-29 that's college savings day. the big dilemma many parents wrestle with is should you fund your 401(k) for your retirement or your child's 529 plan. our senior personal finance correspondent, sharon epperson is here with his answers. i think i know the answer. >> you know the answer but some parents admit they plan to dip into the 401(k) and ira money and delay their own retirement to pay for their kid's education. it's a better alternative because who wants their kid to be saddled with a huge amount of debt. but there are ways to save for college and retirement at the same time so that you don't jeopardize your own financial security. here's a good way to strike a balance and prioritize your savings. the first dollars should go to your 401(k). do that up to the employer match. you want the tax savings. you also don't want to miss out on free money. if you don't have a 401(k) contrib

in the fda collection that seemed to show benefit in terms of stimulating to the cells to make the mylan then they tried that in the mouse model and both of them appeared to have activity in the best animal inned 0le we have that means the next step would be to think about how to move this into a human clinical trial. one of the drugs is antifungal, the other is steroid but neither had been thought of so we're excited about. they might also say there's another exciting finding in ms research in the last month. dr. fauc is institute supported an effort. that was a human trial. >> thank you. the study that dr. collins is referring to that we funded, the allergy and ineffect thus disease because its immunology ically based study. we took 25 individuals who had multiple relapsing ms and performed stem cell transplantation preceded by very aggressive immunosuppression in the same way you give a stem cell transplant for one with neoplastic disease. as its turned out to our great surprise and gratification the numbers were extraordinary. 80% of the 25 people in the trial went into a remission i

>> yes, mylan, this is one that we'll deal at some point.thank you karen. >> pete? >> happy birthday to you, tim. looking at whole foods. down as much as it is. i think a lot of this is priced in. because of that i think down here around the $42 level i think you can start nibbling away at whole foods. >> nibbling no pun intended. i'm mandy drury, catch fast mon again tomorrow night at >>> my mission is simple -- to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere and i promise to help you find it. "mad money" starts no --. hi i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends i'm trying to save you money. i'm trying to educate and teach and coach you, so call me at 1800-743-cnbc or tweet me @jimcramer. thanks for nothing, janet yellen. sheaf used frightening terms to describe the stocks today saying that valuations quote,

and syngenta --teva is in talks to take over mylan. and new england patriots quarterback tom brady says the team championship was not tainted by the championship controversy over deflated footballs. an nfl investigation found that tom brady probably knew about it and he could be suspended and the team could face a major fine. we have less than an hour to go until the close of trading, and let's go right to our breaking news desk where senior advisor julie hyman is there. julie: we have materials technology, health care, and energy leading the game, but these were all groups in the energy sectors that were rising, and we can put this in the laps of the job report. this is just strong enough that it does support economic strength or an economic recovery, and yet just weak enough if you will that the federal reserve does not have to be, at least in theory, aggressive enough about releasing -- rising rates. this has come back up a little bit, and we are also receiving -- also seen that reflected in the dollar. all of the back-and-forth tra

host: mylan tweets into you, is the increase in autism due to it we reported? guest: that is a great question and a tough one. there is a huge increase, no question. the numbers from the cdc beginning back in 2001 they were collecting that data for the current study on epidemiology. they were about one in 500. now it is one in 64. some of that is due to more reporting, without question. that there is no much greater awareness and there are more people who get the label of autism, who may have gotten some other label in the past. it also is probably the case that people who work have not gotten a label in the past because they were quirky or a little shy and withdrawn now might get such a label. that said, for somebody who has been in this field a long time, if you look at those children who have really severe autism, the ones that you would not have missed 30 or 40 years ago, when i started in the field, that was a rare circumstance. in 1985, when i went to do a study with children with autism i have to look long and hard. that would not be the case today. my s

investigators supported by the neurology institute did that screen using the kinds of of cells that use mylan which is the stuff that provides the insulation for nerves. we've been able to show that in a petri dish that there were two drugs in that f.d.a. collection that seemed to show benefit in terms of stimulating those cells to make that. and then they tried that in the mouse model and both appeared to have activity in the best animal we have to. that means the next step would be to think about how to move this into a human clinical trial. one of the drugs is antifungal the other is steroid. but neither of those had ever been thought of in this circumstance. so we're excited about that. i might say there's another exciting finding in multiple sclerosis research only in the last month dr. fauci's institute supported an effort. maybe say something about that. dr. fauci: thank you. the study that dr. collins is referring to that we funded the allergy and infectious disease because it was a study was from our immune tolerance network which was very exciting. we took 25 individuals who had mul

we are also joined by francis mylan, the author and co-author of 18 books including the 3 million the diet for a small planet's. named by gourmet magazine as one of the 25 people whose work is change the way america eats. her most recent work won a silver a silver medal from the independent publisher book awards, cofounder of three organizations she lives with her daughter. they have also cofounded the small planet fund which channels resources to democratic social movements worldwide. please join me in welcoming i speakers command we will get started with molly anderson. [applause] >> thank you. good afternoon to all of you it is a real honor to cope present. i see her has one of the pioneers of food justice. she brought our attention a long time ago to the policies and eating patterns in this country affecting the prospects for justice of people in poor countries. and what we can learn from people in other countries. so i am delighted to be here i want to start with a few observations about why food justice seems to be rising to the four right now wide is on so many people's minds.

i know that teva -- i know teva was interested in mylan. i have no idea how that will pan out.that doesn't work out, they'll make another acquisition. they almost sort of have to. >> on disney bob iger has had an amazing run as ceo. he won't be there forever. he's already identifying who his next successor could be. can they keep this juice going for another ten years? >> well i'll put it this way, he laid about as good of a foundation that a ceo could lay for a successor. the valuation is high. that is going to be an issue. they trade at 20 times blended earnings for the next year. so it's not cheap. they don't have a really good dividend. they keep raising their dividend but their stock keeps going up. who's not going to watch "star wars" and marvel in five ten years, we'll still be watching marvel and "star wars" movies. >> that i follow jon. explain cisco especially since we entered the post-chambers era. >> so cisco is easy. in technology the whole trick? looking at a decade is not to pick the biggest winner out there. it's to pick a company that will be paying you as you

host: mylan tweets into you, is the increase in autism due to it we reported?uest: that is a great question and a tough one. there is a huge increase, no question. the numbers from the cdc beginning back in 2001 they were collecting that data for the current study on epidemiology. they were about one in 500. now it is one in 64. some of that is due to more reporting, without question. that there is no much greater awareness and there are more people who get the label of autism, who may have gotten some other label in the past. it also is probably the case that people who work have not gotten a label in the past because they were quirky or a little shy and withdrawn now might get such a label. that said, for somebody who has been in this field a long time, if you look at those children who have really severe autism, the ones that you would not have missed 30 or 40 years ago, when i started in the field, that was a rare circumstance. in 1985, when i went to do a study with children with autism i have to look long and hard. that would not be the case today. my sen